Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0000950170-24-025189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-04 | 2024-02-29+ | KPTI | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $1.18 | -26.9K | 393.5K | -6% | -$31.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common | 2024-02-29 | S | D | 21,840 | $1.17 | 398,618 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.18, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common | 2024-03-01 | S | D | 5,109 | $1.20 | 393,509 | D | — | — |